INCR - CRVS CTMX and NRXP are among premarket gainers
2024-05-06 08:39:30 ET
More on premarket gainers & stock
- CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling
- CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town
- NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript
- Corvus stock gains amid pricing of $30.6M direct offering
- CytomX surges on upcoming data for Amgen-partnered cancer drug